Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
300049.SZ
HOLDREMOVEInner Mongolia Furui Medical Science Co., Ltd. · Healthcare · China · $1.7B · Avg Vol: $51M/d
Chinese medical diagnostics firm lacking global scale or CDMO pricing power.
COMPANY DESCRIPTION
Inner Mongolia Furui Medical Science Co., Ltd. specializes in the research, development, and production of pharmaceuticals and diagnostic equipment for liver diseases. The company holds a dominant global market position in non-invasive liver fibrosis diagnosis through its French subsidiary Echosens, developer of the industry-standard FibroScan system. This proprietary technology provides a strong competitive moat, positioning Furui as a vertically integrated leader in the hepatology medical device and therapeutics sector.
FINANCIAL SUMMARY
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 149M | 171M | 199M | 236M | 16.5% |
| EPS | 0.05 | 0.06 | 0.06 | 0.09 | 15.9% |
| Shares | 263M | 263M | 266M | 265M | +0.7% |
| Debt | 8M | 9M | 11M | 26M | 46.8% |
| Equity | 228M | 229M | 258M | 292M | 8.6% |
| Op CF | 28M | 45M | 33M | 52M | 22.9% |
| Inv CF | -10M | -22M | -45M | -31M | — |
| Fin CF | -19M | -20M | 20M | -10M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300049.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 300049.SZ | Inner Mongolia Furui Medical Science Co., Ltd.(you) | $1.7B | 40 | HOLD |
| 9887.HK | Nanjing Leads Biolabs Co., Ltd. | $1.6B | 37 | HOLD |
| 2171.HK | CARsgen Therapeutics Holdings Limited | $1.3B | 39 | HOLD |
| 2162.HK | Keymed Biosciences Inc. | $2.3B | 41 | HOLD |
| 688222.SS | HitGen Inc. | $1.8B | 47 | HOLD |
| 688739.SS | Liaoning Chengda Biotechnology Co.,Ltd. | $1.3B | 42 | HOLD |
| 000403.SZ | Pacific Shuanglin Bio-pharmacy Co., Ltd. | $1.8B | 33 | SELL |
| 300497.SZ | Jiangxi Fushine Pharmaceutical Co., Ltd. | $1.2B | 41 | HOLD |
| 301207.SZ | Hualan Biological Vaccine Inc. | $1.6B | 47 | HOLD |
| 688658.SS | Youcare Pharmaceutical Group Co., Ltd. | $1.2B | 39 | HOLD |
Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%